North American Test Strips Market size to exceed $6.7 Bn by 2027

Published Date: 2021-03-22

Request a sample

North American Test Strips Market size is projected to surpass USD 6.7 billion by 2027, according to a latest forecast report by Graphical Research.

Growing geriatric population is prone to chronic diseases such as diabetes and kidney disease that will drive market growth. As per the National Institute of Diabetes & Digestive and Kidney Disease (NIDDK) report, more than 20 million Americans had some level of chronic kidney disease in 2018. Also, the report stated that, the incidence of chronic kidney disease is increasing rapidly in people of 65 years and older. Thus, rising burden of diabetes disease will attract more customers to opt for self-monitoring devices including test strips.

Technological advancement in the blood glucose strips is one of the major factors driving the North American test strips market. Technological advancement in test strips is increasing as the companies are investing in product development and various partnership of strategic collaborations. However, dearth of reimbursement policies for test strips is a major hindering factor for market growth. Also, lack of accuracy in tests conducted with test strips is another chief growth impeding factor.

Urine test strips segment accounted for USD 262.3 million revenue in 2020 attributed to increasing prevalence of urinary tract infections (UTI), mostly in females. For instance, the Canadian Women Health Network reported that around 9% of postmenopausal women indicated that they had a UTI in 2018. Thus, the adoption of urine test strips will increase. Furthermore, rising prevalence of other kidney disorders will boost the product demand.

Browse detailed statistical insights from the report, “North America Test Strips Market Size By End-use (Hospital, Home Care, Diagnostic Laboratories), By Product (Diabetes Test Strips {Thick Film, Thin Film}, Urine Test Strips), Research Report, Country Outlook (Japan, China, India, Australia, New Zealand, Indonesia, South Korea, Singapore, Malaysia, Thailand, Vietnam), Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021 - 2027” along with the table of contents (ToC) @

The hospitals segment size is expected to cross USD 2.1 billion by 2027. Increasing number of diagnostic tests for diabetes as well as other chronic diseases will boost segment growth. Also, increasing number of hospitals in U.S. is another major growth supplementing factor. For instance, according to the American Hospital Directory, the total number of hospitals increased by 7.9% from 2016 to 2018 in U.S.

The Canada test strips market revenue will show a lucrative growth of 2.1% between 2021 and 2027. Increasing prevalence of type-1 diabetes in the country will increase the adoption of glucometers. For instance, according to the Public Health Agency of Canada report, it is estimated that nearly 330,000 people will be suffering from type-1 diabetes by 2025. Thus, patient preference for test strips will increase in the future. Furthermore, home use of test strip is also increasing because of initiatives of provincial governments across Canada. The government have implemented the quantity limits blood glucose test strip (BGTS) to encourage proper testing practices for optimal patient outcomes.

Major market players are Abbott Laboratories, Roche Diabetes Care, Lifescan, B Braun, Siemens Healthineers, Arkray, Henry Schein and Tiadoc among others. These market players focusing on various business strategies such as collaboration and geographic expansion to strengthen their market position. For instance, in May 2017, Roche Diabetes Care launched its Accu-Chek Guide System blood glucose meter product. The product is designed to help simplify diabetes management comprises a spill-resistant test-strip vial. This strategy enabled company in expanding its product portfolio.

The North America test strips market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2016 to 2027, for the following segments:

North America Market, By Product, 2016-2027 (USD Million)

  • Diabetes test strips
    • Thick film test strips
    • Thin film test strips 
  • Urine test strips

North America Market, By End-Use, 2016-2027 (USD Million)

  • Hospitals
  • Home care
  • Diagnostic laboratories
  • Other

The above information has been provided for the following countries:

  • North America
    • U.S.
    • Canada